Sun Pharma recalls 200 vials of cancer drug: FDA

Tags: Companies
Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the US Food and Drug Administration said on Thursday.

The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.

The voluntary recall was initiated in April and was classified by the FDA as Class II, meaning that use of or exposure to the recalled drug may cause temporary or medically reversible adverse health consequences.

This marks Sun Pharma's second drug recall this year. In January, the company started a voluntary recall of about 2,528 bottles of its generic version of diabetes drug Glumetza, after it received a customer complaint that one of the bottles contained tablets of an epilepsy drug.

EDITORIAL OF THE DAY

  • In these three-odd years, BSE Sensex hit a lifetime high of 30,000 from 20,000

    Amassive 1,000 per cent surge in 120 stocks from October 13, 2013 till date, after Narendra Modi was declared BJP’s prime ministerial candidate is s

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Disequilibrium : THE UGLY AND INCONVENIENT TRUTH

Same song, different verse. The time for polemics over how ...

Gautam Datt

Terror comes calling again in Valley

The attack on army camp in Jammu and Kashmir’s Kupwara ...

Kuruvilla Pandikattu

The forgotten hero of science & religion

Young students of science will recognise Albert Einstein, Isaac Newton, ...